RMTIRockwell Medical, Inc.
0.7130USD-3.67%Mkt Cap: 28.26M USDP/E: Last update: 2026-06-01

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure …

Indicators:|

Key Statistics

Company
Market Cap28.26M USD
Enterprise Value
Revenue (TTM)67.68M USD
Gross Profit11.70M USD
Net Income (TTM)-5.31M USD
Revenue/Share1.814 USD
Last Price0.7130 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees157
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS7743743004
Valuation
P/E (Trailing)
P/E (Forward)10.62
PEG4.43
EV/EBITDA
EV/Revenue
P/S0.43
P/B0.79
EPS (TTM)-0.15
EPS (Forward)0.07
52W Range
0.71000% of range2.100
52W High2.100 USD
52W Low0.7100 USD
Profitability
Gross Margin16.89%
Oper. Margin-8.54%
EBITDA Margin-3.86%
Profit Margin-7.67%
ROE-14.37%
ROA-9.30%
Growth
Revenue Growth-8.30%
Earnings Growth
Cash Flow & Leverage
Operating CF-659.00K USD
CapEx (TTM)542.00K USD
FCF Margin
FCF Yield
Net Debt
Net Debt/EBITDA
Balance Sheet
Debt/Equity0.24
Current Ratio
Quick Ratio
Book Value/Sh0.9380 USD
Cash/Share
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:11
Split DateMay 13, 2022
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)3.000 USD
Target Range2.000 USD4.000 USD
# Analysts2
Ownership
Shares Out.39.47M
Float35.20M
Insiders12.25%
Institutions10.13%
Short Interest
Short Ratio1.8d
Short % Float1.27%
Short % Out.1.24%
Shares Short491.30K
Short (prev mo.)990.64K
Technical
SMA 500.8798 (-19.0%)
SMA 2001.042 (-31.6%)
Beta
S&P 52W Chg27.70%
Avg Vol (30d)263.76K
Avg Vol (10d)267.36K
Technical Indicators
RSI (14)32.8
MACD-0.0355
MACD Signal-0.0319
MACD Hist.-0.0037
BB Upper0.8924 USD
BB Middle0.8063 USD
BB Lower0.7203 USD
BB Width21.34%
ATR (14)0.0451 USD
Vol Ratio (20d)0.75x